FiercePharma

Gilead’s stealing hep C share with its cut-rate Eplusa and Harvoni generics

Last September, Gilead made the unexpected move of launching authorized generics to its blockbuster hepatitis C drugs Epclusa and Harvoni, well before their patients expire. Now the copycats have ...
Hackaday

Writing Type-Safe Generics In C

The fun part about a programming language like C is that although the language doesn’t directly support many features including object-oriented programming and generics, there’s nothing that’s keeping ...
Fierce Healthcare

OIG: Part D plans sidestepped cheaper hep C generics for pricey brand-name versions

Some Medicare Part D plans did not cover generic versions of pricey hepatitis C drugs in 2019, leaving millions in savings on the table, according to a new watchdog report. The report, released ...
FiercePharma

Gilead's hepatitis C generics are on their way, but Epclusa's getting TV ads anyway

Gilead Sciences isn't letting a few of its own generics interfere with advertising its pan-genotypic hep C drug Epclusa. The Big Biotech is turning to TV again to promote its hep C franchise, this ...
Modern Healthcare

Gilead's generic hep C drugs may increase access through Medicaid

Gilead Sciences' plan to sell lower-priced generic versions of chronic hepatitis C treatments Harvoni and Epclusa has raised provider hopes that the move will accelerate state efforts to improve ...